DLBCL expression list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Diffuse Large B cell Lymphoma
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

B cell prolymphocytic leukemia

Splenic B cell marginal zone lymphoma

Splenic B cell lymphoma / leukemia

Heavy chain disease

Nodal marginal zone lymphoma

Primary cutaneous follicle center lymhoma

DLBCL associated with chronic inflammation

Lymphomatoid granulomatosis

Primary mediastinal large B cell lymphoma

ALK positive large B cell lymphoma

Plasmablastic lymphoma

Large B cell lymphoma - HHV8 associated multicentric Castleman

B cell lymphoma, unclassifiable with features of DLBCL and Burkitt

B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin

Article	Antigens evaluated
CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.	CD2
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.	CD2, CD4, CD7, CD8
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.	CD5, CD10, CD20, Bcl-6.
Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas.	CD2, CD5, CD7, CD10, CD13, CD33, CD34
Aberrant expression and reverse signalling of CD70 on malignant B cells.	CD27, CD40, CD70
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.	CD5, CD10, CD20, Bcl-2, Bcl-6, Ki-67. (Primarily a gene array study)
Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.	CD99